Erez Chimovits, MBA

Board Member

Erez is a Partner on the OrbiMed Israel team with 14 years of operational experience, including ten years of senior managerial experience in public companies. Prior to joining OrbiMed, Erez was the CEO of NasVax (TASE: NSVX). NasVax acquired Protea and struck agreements with GlaxoSmithKline and Novartis. Previously, Erez spent more than seven years with Compugen (NASDAQ: CGEN), as President, Compugen USA Inc. and Executive V.P., Commercial Operations. At Compugen, he had P&L responsibility for more than 100 people and led multiple transactions with companies including J&J, Novartis, Teva, Abbott, Medarex, and others. Erez earned his MBA, MSc in Microbiology and his BSc from Tel Aviv University.